![Biobot Surgical’s Mona Lisa 2.0 Secures CE Certification: Transforming Prostate Care with Precision, Efficiency, and Versatility for Prostate Biopsy and Ablation | Newswise Biobot Surgical’s Mona Lisa 2.0 Secures CE Certification: Transforming Prostate Care with Precision, Efficiency, and Versatility for Prostate Biopsy and Ablation | Newswise](https://i0.wp.com/mma.prnewswire.com/media/2596028/Biobot_Full_Digital_Logo.jpg?w=600&resize=600,400&ssl=1)
Biobot Surgical’s Mona Lisa 2.0 Secures CE Certification: Transforming Prostate Care with Precision, Efficiency, and Versatility for Prostate Biopsy and Ablation | Newswise
Newswise — SINGAPORE, Jan. 14, 2025 /PRNewswire/ — Biobot Surgical, an innovator in robotic-assisted prostate disease management, is proud to announce that the Mona Lisa 2.0 has received CE Certification, adding to the US FDA, Australia TGA and Singapore HSA approvals. This milestone paves the way for Mona Lisa 2.0 to be utilized in clinical settings across…